Федеральное государственное бюджетное учреждение науки Иркутский институт химии им. А.Е. Фаворского Сибирского отделения Российской академии наук (RU)
发明人:
Сухов Борис Геннадьевич (RU),Ганенко Татьяна Васильевна (RU),Погодаева Наталья Николаевна (RU),Кузнецов Сергей Викторович (RU),Силкин Иван Иванович (RU),Лозовская Евгения Александровна (RU),Шурыгин Ми
申请号：
RU2015132794
公开号：
RU2015132794A
申请日:
2015.08.05
申请国别(地区):
RU
年份:
2017
代理人:
摘要：
FIELD: pharmacy.SUBSTANCE: method of agent production includes interation of raw arabinogalactan and selenium dioxide or selenious acid salt in a solvent followed by precipitation in ethanol or acetone, or other organic solvent capable of mixing with water. The peculiarity of this method is that the process is carried out at the temperature of 20-25°C, stable selenium nanoparticles size is 0.5-250 nm, and raw arabinogalactan or arabinogalactan specially purified from phenolic impurities is used as the raw materila, while water or dimethylsulfoxide, or formamide are used as solvents.EFFECT: soluble stable nanocomposites providing antitumor activity, in dry form.3 cl, 7 dwg, 11 ex
